mRNA has emerged as an important biomolecule in the global call for the development of therapies during the COVID-19 pandemic. Synthetic in vitro-transcribed (IVT) mRNA can be engineered to mimic naturally occurring mRNA and can be used as a tool to target "undruggable" diseases. Recent advancement in the field of RNA therapeutics have addressed the challenges inherent to this drug molecule and this approach is now being applied to several therapeutic modalities, from cancer immunotherapy to vaccine development. In this review, we discussed the use of mRNA for stem cell generation or enhancement for the purpose of cardiovascular regeneration.

Original languageEnglish (US)
Issue number1
StatePublished - Jan 19 2021


  • RNA therapeutics
  • cardiovascular ageing
  • cardiovascular regeneration
  • cell therapy
  • iPSCs
  • inflammatory signaling
  • nuclear reprogramming
  • transdifferentiation

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'mRNA-Enhanced Cell Therapy and Cardiovascular Regeneration'. Together they form a unique fingerprint.

Cite this